Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.
Event: ESC Congress 2019
Topic: Diabetes and the Heart
Session: Diabetes and the heart
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
Event: ESC Congress 2019
Topic: Secondary Prevention
Session: Young Investigator Award Session Thrombosis
Estimating individual cardiovascular disease risk reduction by blood pressure lowering in elderly patients: results from the HYVET study
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Hypertension - Risk profiling and treatment
ESC 365 is supported by
